Molecular biology of pharmacologic vitreolysis

Transactions of the American Ophthalmological Society

Volumn 103, Issue , 2005, Pages 473-494

  Sebag, J ^a,b  

^a VMR Institute   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGENASE; FIBRINOLYTIC AGENT; HYALURONIC ACID; HYALURONIDASE; MICROPLASMIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG MECHANISM; EXPLANT; LIGHT SCATTERING; MACROMOLECULE; MOLECULAR BIOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REPRODUCIBILITY; VARIANCE; VITREOUS BODY;

ANIMALS; CATTLE; COLLAGEN; COLLAGENASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYSIN; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; LIGHT; MACROMOLECULAR SUBSTANCES; MICROSCOPY; MOLECULAR BIOLOGY; PLASMIN; REPRODUCIBILITY OF RESULTS; SCATTERING, RADIATION; SOLUTIONS; SWINE; TIME FACTORS; VITREOUS BODY;

EID: 29944443425     PISSN: 15456110     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Sebag J, Balazs EA. Pathogenesis of C.M.E: anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol 1984;28(suppl):493-498.
2. Sebag J, Balazs EA. Human vitreous fibres and vitreoretinal disease. Trans Ophthalmol Soc U K 1985;104:123-128.
3. Sebag J, Balazs EA. Morphology and ultrastructure of human. Vitreous fibers. Invest Ophthalmol Vis Sci 1989;30:1867-1871.
4. Foulds WS. Is your vitreous really necessary? The role of the vitreous in the eye with particular reference to retinal attachment, detachment and the mode of action of vitreous substitutes. (The 2nd Duke-Elder Lecture). Eye 1987;1:641-664.
5. Sebag J. The vitreous: structure, function and pathobiology. New York: Springer-Verlag; 1989.
6. Sebag J. Macromolecular structure of vitreous. Progr Polym Sci 1998;23:415-446.
7. Sebag J. Vitreous - from biochemistry to clinical relevance. In: Tasman W, Jaeger EA, eds. Duane's Foundations of Clinical Ophthalmology. Vol 1, chap 16. Philadelphia: Lippincott Williams & Wilkins; 1998.
8. Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Ret Eye Res 2000;19:323-344.
9. Balazs EA. Molecular morphology of the vitreous body. In: Smelser GK, ed. The Structure of the Eye. New York & London: Academic Press; 1961:293-310.
10. Sheehan JK, Atkins EDT, Nieduszynski IA. X-Ray diffraction studies on the connective tissue polysaccharides. Two dimensional packing scheme for threefold hyaluronic chains. J Mol Biol 1975;91:153-163.
11. Balazs EA. Functional anatomy of the vitreus. In: Duane TD, Jaeger EA, eds. Biomedical Foundations of Ophthalmology. Philadelphia: Harper & Row; 1984:14.
12. Seery CM, Davison PF. Collagens of the bovine vitreous. Invest Ophthalmol Vis Sci 1991;32:1540-1550.
13. Mayne R. The eye. In: Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders. New York: Wiley-Liss; 2002:131-141.
14. Comper WD, Laurent TC. Physiological functions of connective tissue polysaccharides. Physiol Rev 1978;58:255-315.
15. Scott JE, Chen Y, Brass A. Secondary and tertiary structures involving chondroitin and chondroitin sulphate in solution, investigated by rotary shadowing electron microscopy and computer simulation. Eur J Biochem 1992;209:675-680.
16. Mayne R, Brewton RG, Ren Z-H. Vitreous body and zonular apparatus. In: Harding JJ, ed. Biochemistry of the Eye. London: Chapman and Hall; 1997:135-143.
17. Sebag J. Age-related differences at the human vitreo-retinal interface. Arch Ophthalmol 1991;109:966-971.
18. Russell SR, Shepherd JD, Hageman GS. Distribution of glycoconjugates in the human internal limiting membrane. Invest Ophthalmol Vis Sci 1991;32:1986-1995.
19. Sebag J. Anomalous PVD - a unifying concept in vitreo-retinal disease. Graefes Arch Clin Exp Ophthalmol 2004;242:690-698.
20. Chu T, Lopez PF, Cano MR, et al. Posterior Vitreoschisis - an echographic finding in proliferative diabetic retinopathy. Ophthalmology 1996;103:315-322.
21. Personal communication. For more information, see:Hageman GS, Russell SR Chondroitinase-mediated disinsertion of the primate vitreous body. Invest Ophthalmol Vis Sci 1994; 35(ARVO):1260.
22. Verstraeten T, Chapman C, Hartzer M, et al. Pharmacologic induction of PVD in the rabbit. Arch Ophthalmol 1993;111:849-854.
23. Hikichi T, Yanagiya N, Kado M, et al. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina 1999;19:55-58.
24. Tezel TH, Del Priore LV, Kaplan HJ. Posterior vitreous detachment with dispase. Retina 1998;18:7-15.
25. Bishop PN, McLeod D, Reardon A. Effects of hyaluronan lyase, hyaluronidase, and chondroitin ABC lyase on mammalian vitreous gel. Invest Ophthalmol Vis Sci 1999;40:2173-2178.
26. Unal M, Peyman GA. The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment. Retina 2000;20:69-75.
27. Hesse L, Nebeling B, Schroeder B, et al. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy. Exp Eye Res 2000;70:31-39.
28. Oliviera LB, Tatebayashi M, Mahmoud TH, et al. Dispase facilitates posterior vitreous detachment during vitrectomy in young pigs. Retina 2001;21:324-331.
29. Jorge R, Oyamagucji EK, Cardillo JA, et al. Intravitreal injection of dispase causes retinal hemorrhages in rabbit and human eyes. Curr Eye Res 2003;26:107-112.
30. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmology 2000;107:1607-1611.
31. Williams JG, Trese MT, Williams GA, et al. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology 2001;108:1902-1905.
32. Valmaggia C, Willekens B, de Smet M. Microplasmin induced vitreolysis in porcine eyes. Invest Ophthalmol Vis Sci 2003;44(ARVO):3050.
33. Gandorfer A, Rohleder M, Sethi C, et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci 2004;45:641-647.
34. Laroche Y, Collen D. Recombinant human microplasmin: production and potential therapeutic properties. Thromb Haemost 2003;1:307-313.
35. Ansari RR, Suh KI, Arabshahi A, et al. A fiber optic probe for monitoring protein aggregation, nucleation and crystallization. J Crystal Growth 1996;168:216-226.
36. Ansari RR. Ocular static and dynamic light scattering: a non-invasive diagnostic tool for eye research and clinical practice. J Biomed Opt 2004;9:46-57.
37. Datiles MB, Ansari RR, Reed GF. A clinical study of the human lens with a dynamic light scattering device. Exp Eye Res 2002;74:93.
38. Datiles MB, Ansari RR. Evaluation of cataracts. In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology. Philadelphia: Lippincott Williams & Wilkins; 2004: chap 73-B.
39. Ansari RR, Dunker S, Suh K, et al. Quantitative molecular characterization of bovine vitreous and lens with non-invasive dynamic light scattering. Exp Eye Res 2001;73:859-866.
40. Sebag J, Ansari RR, Dunker S, et al. Dynamic light scattering of diabetic vitreopathy. Diabetes Technol Ther 1999;1:169-176.
41. Sebag J. Diabetic vitreopathy. Ophthalmology 1996;103:205-206.
42. Sebag J. Myopia effects upon vitreous - significance for retinal detachments. Acta V International Congress on Vitreo-Retinal Surgery (M. Stirpe, ed). New York: Ophthalmic Communications Society Inc; 1998:366-372.
43. Sebag J. Pharmacologic vitreolysis. Retina 1998;18:1-3.
44. Sebag J. Is pharmacologic vitreolysis brewing? Retina 2002;22:1-3.
45. Wang ZL, Zhang X, Xu X, et al. PVD following plasmin but not hyaluronidase - implications for combination pharmacologic vitreolysis therapy. Retina 2005;25:38-43.
46. Hikichi T, Masanori K, Yoshida A. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit. Retina 2000;20:195-198.
47. Lauer-Fields JL, Fields GB. Triple-helical peptide analysis of collagenolytic protease activity. Biol Chem 2002;383:1095-1105.
48. Lauer-Fileds JL, Sritharan T, Stack MS, et al. Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9. J Biol Chem 2003;278:18140-18145.
49. Schachat AP, Chambers W, Liesegang TJ, et al. Safe and effective. Ophthalmology 2003;110:2073-2074.
50. Chu B. Laser light scattering: basic principles and practice. New York: Academic Press; 1991.
51. Stock RS, Ray WH. Interpretation of photon correlation data: a comparison of analysis methods. J Polym Sci 1985;23:1393-1447.